Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors

Glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of antihyperglycemic drugs that enhance appropriate pancreatic β-cell secretion, pancreatic α-cell (glucagon) suppression, decrease liver glucose production, increase satiety through their action on the central nervous system, slow ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Klen, Jasna, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998939/
https://www.ncbi.nlm.nih.gov/pubmed/35408810
http://dx.doi.org/10.3390/ijms23073451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998939/
https://www.ncbi.nlm.nih.gov/pubmed/35408810
http://dx.doi.org/10.3390/ijms23073451

Ejemplares similares